Bar Harbor Wealth Management Bristol Myers Squibb CO Transaction History

Bar Harbor Wealth Management

$1.51 Billion
Q4 2024

A detailed history of Bar Harbor Wealth Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bar Harbor Wealth Management holds 38,789 shares of BMY stock, worth $2.37 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

38,789

Previous 39,849 2.66%

Holding current value

$2.37 Million

Previous $2.06 Million 6.35%

% of portfolio

0.14%

Previous 0.13%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2024 Jan 13, 2025	SELL	$51.92 - $59.94 $55,035 - $63,536	-1,060 Reduced 2.66%	38,789 $2.19 Million
Q3 2024 Oct 16, 2024	SELL	$39.66 - $51.75 $24,311 - $31,722	-613 Reduced 1.52%	39,849 $2.06 Million
Q2 2024 Jul 17, 2024	SELL	$40.25 - $52.99 $76,515 - $100,733	-1,901 Reduced 4.49%	40,462 $1.68 Million
Q1 2024 Apr 23, 2024	BUY	$47.98 - $54.4 $364,264 - $413,004	7,592 Added 21.83%	42,363 $2.3 Million
Q4 2023 Jan 17, 2024	SELL	$48.48 - $57.85 $50,613 - $60,395	-1,044 Reduced 2.91%	34,771 $1.78 Million
Q3 2023 Nov 28, 2023	SELL	$57.89 - $64.73 $75,488 - $84,407	-1,304 Reduced 3.51%	35,815 $2.08 Million
Q2 2023 Aug 09, 2023	SELL	$63.71 - $70.74 $108,115 - $120,045	-1,697 Reduced 4.37%	37,119 $2.37 Million
Q1 2023 Apr 24, 2023	SELL	$65.71 - $74.53 $1,445 - $1,639	-22 Reduced 0.06%	38,816 $2.69 Million
Q4 2022 Jun 09, 2023	BUY	$68.48 - $81.09 $1,506 - $1,783	22 Added 0.06%	38,838 $2.79 Million
Q4 2022 Jan 19, 2023	BUY	$68.48 - $81.09 $27,871 - $33,003	407 Added 1.06%	38,838 $2.8 Million
Q3 2022 Oct 24, 2022	SELL	$0.13 - $76.84 $136 - $80,758	-1,051 Reduced 2.66%	38,431 $2.73 Million
Q2 2022 Aug 12, 2022	BUY	$72.62 - $79.98 $698,604 - $769,407	9,620 Added 32.21%	39,482 $3.04 Million
Q1 2022 Apr 14, 2022	SELL	$61.48 - $73.72 $126,710 - $151,936	-2,061 Reduced 6.46%	29,862 $2.18 Million
Q4 2021 Jan 28, 2022	SELL	$53.63 - $62.52 $28,155 - $32,823	-525 Reduced 1.62%	31,923 $1.99 Million
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $887 - $1,039	-15 Reduced 0.05%	32,448 $1.92 Million
Q2 2021 Aug 11, 2021	SELL	$61.91 - $67.42 $38,384 - $41,800	-620 Reduced 1.87%	32,463 $2.17 Million
Q1 2021 May 06, 2021	SELL	$59.34 - $66.74 $27,296 - $30,700	-460 Reduced 1.37%	33,083 $2.09 Million
Q3 2020 Nov 02, 2020	SELL	$57.43 - $63.64 $18,779 - $20,810	-327 Reduced 0.97%	33,543 $2.02 Million
Q2 2020 Aug 04, 2020	SELL	$54.82 - $64.09 $102,623 - $119,976	-1,872 Reduced 5.24%	33,870 $1.99 Million
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $241,558 - $351,040	-5,206 Reduced 12.71%	35,742 $1.99 Million
Q4 2019 Feb 11, 2020	BUY	$49.21 - $64.19 $167,658 - $218,695	3,407 Added 9.08%	40,948 $2.63 Million
Q3 2019 Nov 07, 2019	SELL	$42.77 - $50.71 $37,423 - $44,371	-875 Reduced 2.28%	37,541 $1.9 Million
Q2 2019 Aug 01, 2019	BUY	$44.62 - $49.34 $41,853 - $46,280	938 Added 2.5%	38,416 $1.74 Million
Q1 2019 May 10, 2019	SELL	$45.12 - $53.8 $31,493 - $37,552	-698 Reduced 1.83%	37,478 $1.79 Million
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $53,684 - $69,616	-1,101 Reduced 2.8%	38,176 $1.98 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $7,781 - $8,777	-141 Reduced 0.36%	39,277 $2.44 Million
Q2 2018 Aug 10, 2018	SELL	$50.53 - $62.98 $113,288 - $141,201	-2,242 Reduced 5.38%	39,418 $2.18 Million
Q1 2018 Apr 06, 2018	BUY	$59.92 - $68.98 $194,680 - $224,116	3,249 Added 8.46%	41,660 $2.64 Million
Q4 2017 Jan 17, 2018	BUY	$59.94 - $65.35 $101,298 - $110,441	1,690 Added 4.6%	38,411 $2.35 Million
Q3 2017 Oct 11, 2017	BUY	$55.23 - $63.74 $2.03 Million - $2.34 Million	36,721	36,721 $2.34 Million

Others Institutions Holding BMY

# of Institutions

2,765

Shares Held

1.57B

Call Options Held

28M

Put Options Held

28.7M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $130B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bar Harbor Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Bar Harbor Wealth Management with notifications on news.

Account

Bar Harbor Wealth Management Bristol Myers Squibb CO Transaction History